Bringing Allogeneic CAR-T Cell Therapies to Fruition by Developing Strategies for Multiplexed Engineering using chRDNA Genome-Editing Platform

Time: 2:00 pm
day: Day One


• Creating processes to produce highly efficacious allogeneic cell therapies with potential to expand to new markets
• Sharing engineering strategies to enhance persistence of allogeneic cells that may translate to improved clinical outcomes
• Establishing dosage requirements to inform batch size and manufacturing scale for off-the-shelf therapies